Learn Look Locate, Pfizer, and Imerman Angels Launch Global Initiative to Ensure Patients Worldwide Have Timely Access to the Latest Advances in Stage 4 Breast Cancer Treatment “With Stage IV ...

The HER2-targeted antibody-drug conjugate that Pfizer gained from its Seagen buyout has delivered positive results in a pivotal study among Chinese patients with newly diagnosed bladder cancer ...

On May 19, Pfizer Inc. (NYSE:PFE) announced it had entered into a licensing agreement valued at approximately $6 billion with Chinese biopharmaceutical firm 3SBio Inc. for the development ...

(Reuters) -U.S. drugmaker Pfizer said it would license an experimental cancer treatment from China's 3SBio Inc, paying $1.25 billion upfront and up to another $4.8 billion if developmental ...

metastatic colorectal cancer, and gynecological tumors in China. 3SBio plans to initiate Phase 3 trials there in 2025. The transaction gives Pfizer manufacturing and commercialization rights ...

The forward’s three-goal third period put AstraZeneca over the top in the season-long NHL Hat Trick Challenge, reaching its donation ... Fights Cancer was founded in 1998 as a joint initiative ...

Chris Boshoff, Pfizer’s chief oncology officer Its new chief oncology officer, Dr Chris Boshoff, said the focus will be on four main cancer types: breast cancer, genitourinary cancers including ...

He launched the moonshot after his son, Beau, died from brain cancer in 2015. A day after it was announced he had prostate cancer, former President Joe Biden posted on Monday that "cancer touches ...